Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 21, 2021

SELL
$60.0 - $68.46 $275,160 - $313,957
-4,586 Closed
0 $0
Q4 2020

Feb 25, 2021

SELL
$56.65 - $64.55 $47,642 - $54,286
-841 Reduced 15.5%
4,586 $297,000
Q3 2020

Nov 03, 2020

SELL
$62.1 - $78.08 $18,071 - $22,721
-291 Reduced 5.09%
5,427 $343,000
Q2 2020

Aug 10, 2020

BUY
$72.34 - $84.0 $9,187 - $10,668
127 Added 2.27%
5,718 $440,000
Q1 2020

May 22, 2020

BUY
$62.63 - $80.22 $350,164 - $448,510
5,591 New
5,591 $418,000
Q4 2019

Feb 06, 2020

SELL
$61.62 - $67.78 $205,934 - $226,520
-3,342 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$62.51 - $69.0 $49,945 - $55,131
-799 Reduced 19.29%
3,342 $212,000
Q2 2019

Aug 12, 2019

BUY
$61.87 - $69.38 $256,203 - $287,302
4,141 New
4,141 $270,000
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $300,331 - $336,450
-4,803 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$60.54 - $79.0 $711,768 - $928,803
-11,757 Reduced 71.0%
4,803 $325,000
Q3 2018

Oct 25, 2018

SELL
$71.28 - $78.92 $30,294 - $33,541
-425 Reduced 2.5%
16,560 $1.13 Million
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $135,080 - $157,565
2,082 Added 13.97%
16,985 $1.2 Million
Q1 2018

May 01, 2018

BUY
$72.84 - $88.8 $380,079 - $463,358
5,218 Added 53.88%
14,903 $1.12 Million
Q4 2017

Feb 02, 2018

SELL
$71.15 - $83.52 $689,158 - $808,974
-9,686 Reduced 50.0%
9,685 $694,000
Q3 2017

Oct 06, 2017

BUY
$72.11 - $85.47 $1.4 Million - $1.66 Million
19,371
19,371 $1.62 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Patton Albertson Miller Group, LLC Portfolio

Follow Patton Albertson Miller Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.